Clinical Trial Update: A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions [Phase 1]

View source ↗

Summary

This Phase 1 study compares the relative bioavailability and pharmacodynamic profiles of Zegerid 20 mg capsule, Zegerid 20 mg powder for oral suspension, and Lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acid Reflux
• Gastroesophageal Reflux Disease

Drugs mentioned

• Losec 20 mg Capsule (omeprazole)
• Zegerid 20 mg Capsule (omeprazole with sodium bicarbonate)
• Zegerid 20 mg Powder for Oral Suspension (omeprazole with sodium bicarbonate)

Snippet

Sponsor: Norgine | Conditions: Acid Reflux, Gastro Oesophageal Reflux Disease | Phase 1 | Status: COMPLETED